IP Library › Granted Patent US 11,376,230
Granted Patent B2
US 11,376,230 · App. 14/112,518 · Granted Jul 5, 2022

Wound care product

Inventors: Thomas Bjarnsholt (Soborg, DK); Klaus Kirketerp-Moller (Koge, DK); Michael Christian Givskov (Humlebaek, DK)
Assignees: Rigshospitalet Copenhagen University Hospital; Bispebjerg Hospital
A61K31/194A61F13/0206A61F13/0216A61K9/7007A61L15/46A61L26/0066A61M1/0023A61K9/0014A61L2300/102A61L2300/404Y02A50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,376,230
App. No.
14/112,518
Granted
Jul 5, 2022
Kind
B2
Abstract

The present invention pertains to use of sodium diacetate (NaHAc 2 ) as an antimicrobial agent against bacteria growing in biofilms. The aspects of the invention include a wound care product comprising sodium diacetate, a kit comprising a wound care product, and a method of treating an infected wound.

Claims (8)

1. A wound care product configured to treat wound infections comprising microbial biofilm, the wound care product consisting of an amount of sodium diacetate in dry form, the amount effective for treating a microbial biofilm infection within a wound area, and a carrier device including the amount of sodium diacetate embedded within a portion thereof and configured to place the amount of sodium diacetate into direct contact with the wound, wherein the sodium diacetate is the only active ingredient provided in the wound care product.

2. The wound care product according to claim 1 , wherein the sodium diacetate is a powder.

3. The wound care product according to claim 1 , wherein the particle size of sodium diacetate is in the range of 2 mm to 0.001 mm.

4. The wound care product according to claim 1 , wherein sodium diacetate is embedded in the carrier device in an amount in the range of 0.01-200 mg/cm3.

5. The wound care product according to claim 1 , wherein sodium diacetate is distributed on a surface of the carrier device in an amount in the range of 0.01-2 mg/cm2.

6. The wound care product according to claim 1 , wherein the carrier device is selected from a group consisting of a dressing, foam, gauze, bandage, gel, or paste.

7. The wound care product according to claim 1 , wherein sodium diacetate is the only antimicrobial and/or antibacterial ingredient in said product.

8. A kit comprising the wound care product according to claim 1 and an adhesive membrane.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 18, 2016
From: DANMARKS TEKNISKE UNIVERSITET
To: RIGSHOSPITALET; BISPEBJERG HOSPITAL
Reel/Frame 038638/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2013
From: BJARNSHOLT, THOMAS
To: RIGSHOSPITALET
Reel/Frame 031475/0966 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2013
From: MOLLER, KLAUS KIRKETERP
To: BISPEBJERG HOSPITAL
Reel/Frame 031476/0078 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2013
From: GIVSKOV, MICHAEL CHRISTIAN
To: DANMARKS TEKNISKE UNIVERSITET
Reel/Frame 031476/0164 →
Priority Claims (1)
EP 1162912 · Apr 18, 2011 · regional
Continuity (1)
Related Publication 20140046276A1 · Feb 13, 2014